Mesenchymal stem cell and regenerative medicine: Regeneration versus immunomodulatory challenges

American Journal of Stem Cells

Volumn 2, Issue 1, 2013, Pages 22-38

  Law, Sujata ^a   Chaudhuri, Samaresh ^b  

^a CALCUTTA SCHOOL OF TROPICAL MEDICINE   (India)

^b MAULANA ABUL KALAM AZAD UNIVERSITY OF TECHNOLOGY   (India)

Author keywords

Immunology; Mesenchymal stem cell; MSC application limitations; MSC therapy

Indexed keywords

5' NUCLEOTIDASE; CD14 ANTIGEN; CD34 ANTIGEN; CD45 ANTIGEN; CHEMOKINE RECEPTOR; ENDOGLIN; HEME OXYGENASE 1; HLA DR ANTIGEN; INDOLEAMINE 2,3 DIOXYGENASE; INTERCELLULAR ADHESION MOLECULE 1; INTERLEUKIN 10; MONOCYTE CHEMOTACTIC PROTEIN 1; NITRIC OXIDE; PROSTAGLANDIN E2; SCATTER FACTOR; TRANSFORMING GROWTH FACTOR BETA1;

ARTHRITIS; AUTOIMMUNE DISEASE; BONE DEFECT; CELL TRANSFORMATION; HEART INFARCTION; HEART MUSCLE INJURY; HEMATOPOIESIS; HUMAN; IMMUNE RESPONSE; IMMUNOCOMPETENT CELL; IMMUNOMODULATION; IMMUNOSUPPRESSIVE TREATMENT; LUNG FIBROSIS; MAJOR HISTOCOMPATIBILITY COMPLEX; MESENCHYMAL STEM CELL; MESENCHYMAL STEM CELL TRANSPLANTATION; NONHUMAN; OSTEOPOROSIS; PARKINSON DISEASE; REGENERATIVE MEDICINE; REVIEW; SPINAL CORD INJURY;

EID: 85026338977     PISSN: None     EISSN: 21604150     Source Type: Journal    
DOI: None     Document Type: Review

References (149)

1. Prockop DJ. Marrow Stromal cells as stem cells for non-hematopoietic tissues. Science 1997; 276: 71-74.
2. Weiss L. The hematopoietic microenvironment of the bone marrow: An ultrastructural study of the stroma in rats. Anat Rec 1976; 186: 161-184.
3. Lichtman MA. The ultrastructure of the hemopoietic environment of the marrow: A review. Exp Hematol 1981; 9: 391-410.
4. Bianco P, Riminucci M, Kuznetsov S and Robey PG. Multipotential cells in the bone marrow stroma: regulation in the context of organ physiology. Crit Rev Eukaryot Gene Expr 1999; 9: 159-173.
5. Friedenstein AJ. Osteogenic stem cells in the bone marrow. Bone Min Res 1990; 7: 243-272.
6. Yañez R, Lamana ML, García-Castro J, Colmenero I, Ramírez M and Bueren JA. Adipose tissue-derived mesenchymal stem cells have in vivo immunosuppressive properties applicable for the control of the graft-versus-host disease. Stem Cells 2006; 24: 2582-2591.
7. Owen M. Marrow stromal stem cells. J Cell Sci 1988; 10: 63-76.
8. Miura M, Gronthos S, Zhao M, Lu B, Fisher LW, Robey PG and Shi S. SHED: stem cells from human exfoliated deciduous teeth. Proc Natl Acad Sci U S A 2003; 100: 5807-5812.
9. Caplan AI and Goldberg VM. Treatment of osteochondral defects with autologous bone marrow in a hyaluronan-based delivery vehicle. Tissue Eng 2002; 8: 333-347.
10. Koc ON, Day J, Nieder M, Gerson SL, Lazarus HM and Krivit W. Allogeneic mesenchymal stem cell infusion for treatment of metachromatic leukodystrophy (MLD) and Hurler syndrome (MPS-IH). Bone Marrow Transplant 2002; 30: 215-222.
11. D'Ippolito G, Schiller PC, Ricordi C, Roos BA and Howard GA. Age-related osteogenic potential of mesenchymalstromal stem cells from human vertebral bone marrow. J Bone Miner Res 1999; 14: 1115-1122.
12. Belema-Bedada F, Uchida S, Martire A, Kostin S and Braun T. Efficient homing of multipotent adult mesenchymal stem cells depends on FROUNT-mediated clustering of CCR2. Cell Stem Cell 2008; 2: 566-575.
13. Nakahara H, Bruder SP, Haynesworth SE, Holecek JJ, Baber MA, Goldberg VM and Caplan AI. Bone and cartilage formation in diffusion chambers by subcultured cells derived from the periosteum. Bone 1990; 11: 181-188.
14. Gronthos S, Mankani M, Brahim J, Robey PG and Shi S. Postnatal human dental pulp stem cells (DPSCs) in vitro and in vivo. Proc Natl Acad Sci U S A 2000; 97: 13625-13630.
15. Romanov YA, Svintsitskaya VA and Smirnov VN. Searching for alternative sources of postnatal human mesenchymal stem cells: candidate MSC-like cells from umbilical cord. Stem Cells 2003; 21: 105-110.
16. Seo MS, Kim HS, Shin TH, Yang SR, Kim DJ, Kang SK, Park JH and Kang KS. Implication of NOD1 and NOD2 for the differentiation of multipotent mesenchymal stem cells derived from human umbilical cord blood. PLoS ONE 2010; 5: e15369.
17. Pountos I and Giannoudis PV. Biology of mesenchymal stem cells. Injury 2005; 36: S8-S12.
18. Bi Y, Ehirchiou D, Kilts TM, Inkson CA, Embree MC, Sonoyama W, Li L, Leet AI, Seo BM, Zhang L, Shi S and Young MF. Identification of tendon stem/progenitor cells and the role of the extracellular matrix in their niche. Nat Med 2007; 13: 1219-1227.
19. Zannettino AC, Paton S, Arthur A, Khor F, Itescu S, Gimble JM and Gronthos S. Multipotential human adipose-derived stromal stem cells exhibit a perivascular phenotype in vitro and in vivo. J Cell Physiol 2008; 214: 413-421.
20. Baddoo M, Hill K, Wilkinson R, Gaupp D, Hughes C, Kopen GC, Phinney DG. Characterization of mesenchymal stem cells isolated from murine bone marrow by negative selection. J Cell Biochem 2003; 89: 1235-1249.
21. Miura M, Gronthos S, Zhao M, Lu B, Fisher LW, Robey PG and Shi S. SHED: stem cells from human exfoliated deciduous teeth. Proc Natl Acad Sci U S A 2003; 100: 5807-5812.
22. Djouad F, Plence P, Bony C, Tropel P, Apparailly F, Sany J, Noel D and Jorgensen C. Immunosuppressive effect of mesenchymal stem cells favors tumor growth in allogeneic animals. Blood 2003; 102: 3837-3844.
23. Sacchetti B, Funari A, Michienzi S, Di Cesare S, Piersanti S, Saggio I, Tagliafico E, Ferrari S, Robey PG, Riminucci M and Bianco P. Self-renewing osteoprogenitors in bonemarrow sinusoids can organize a hematopoietic microenvironment. Cell 2007; 131: 324-336.
24. Covas DT, Panepucci RA, Fontes AM, Silva WA Jr, Orellana MD, Freitas MC, Neder L, Santos AR, Peres LC, Jamur MC and Zago MA. Multipotent mesenchymal stromal cells obtained from diverse human tissues share functional properties and gene-expression profile with CD146{thorn} perivascular cells and fibroblasts. Exp Hematol 2008; 36: 642-654.
25. da Silva Meirelles L, Chagastelles PC and Nardi NB. Mesenchymal stem cells reside invirtually all post-natal organs and tissues. J Cell Sci 2006; 119: 2204-2213.
26. Haynesworth SE, Baber MA and Caplan AI. Cell surface antigens on human marrow-derived mesenchymal cells are detected by monoclonal antibodies. Bone 1992; 13: 69-80.
27. Galmiche MC, Koteliansky VE and Briere J. Stromal cells from human long-term marrow cultures are mesenchymal cells that differentiate following a vascular smooth muscle differentiation pathway. Blood 1993; 82: 66-76.
28. Pittenger MF, Mackay AM and Beck SC. Multi-lineage potential of adult human mesenchymal stem cells. Science 1999; 284: 143-147.
29. Sordi V, Malosio ML and Marchesi F. Bone marrow mesenchymal stem cells express a restricted set of functionally active chemokine receptors capable of promoting migration to pancreatic islets. Blood 2005; 106: 419-427.
30. Le Blanc K, Tammik C and Rosendahl K. HLA expression and immunologic properties of differentiated and undifferentiated mesenchymal stem cells. Exp Hematol 2003; 31: 890-896.
31. Baddoo M, Hill K and Wilkinson R. Characterization of mesenchymal stem cells isolated from murine bone marrow by negative selection. J Cell Biochem 2003; 89: 1235-1249.
32. Jones EA, Kinsey SE and English A. Isolation and characterization of bone marrow multipotential mesenchymal progenitor cells. Arthritis Rheum 2002; 46: 3349-3360.
33. Gindraux F, Selmani Z and Obert L. Human and rodent bone marrow mesenchymal stem cells that express primitive stem cell markers can be directly enriched by using the CD49a molecule. Cell Tissue Res 2007; 327: 471-483.
34. Peister A, Mellad JA and Larson BL. Adult stem cells from bone marrow (MSCs) isolated from different strains of inbred mice vary in surface epitopes, rates of proliferation, and differentiation potential. Blood 2004; 103: 1662-1668.
35. Mabuchi Y, Houlihan DD, Okano H and Matsuzaki Y. Discovering the true identity and function of Mesenchymal Stem Cells. Inflammation and Regeneration 2012; 32: 146-151.
36. Méndez-Ferrer S, Michurina TV, Ferraro F, Mazloom AR, Macarthur BD, Lira SA, Scadden DT, Ma'ayan A, Enikolopov GN, Frenette PS. Mesenchymal and haematopoietic stem cells form a unique bone marrow niche. Nature 2010; 466: 829-834.
37. Gronthos S, Simmons PJ and Graves SE. Integrin-mediated interactions between human bone marrow stromal precursor cells and the extracellular matrix. Bone 2001; 28: 174-181.
38. Javazon EH, Beggs KJ and Flake AW. Mesenchymal stem cells: Paradoxes of passaging. Exp Hematol 2004; 32: 414-425.
39. Le Blanc K and Ringden O. Immunobiology of human mesenchymal stem cells and future use in hematopoietic stem cell transplantation. Biol Blood Marrow Transplant 2005; 11: 321-334.
40. Gotherstrom C, Ringden O and Tammik C. Immunologic properties of human fetal mesenchymal stem cells. Am J Obstet Gynecol 2004; 190: 239-245.
41. Simmons PJ and Torok-Storb B. Identification of stromalcell precursors in human bone marrow by a novel monoclonal antibody, STRO-1. Blood 1991; 78: 55-62.
42. Krebsbach PH, Mankani MH, Satomura K, Kuznetsov SA and Robey PG. Repair of craniotomy defects using bone marrow stromal cells. Transplantation 1997; 66: 1272-1278.
43. Pittenger MF, Mackay AM, Beck SC, Jaiswal RK, Douglas R, Mosca JD, Moorman MA, Simonetti DW, Craig S and Marshak DR. Multilineage potential of adult human mesenchymal stem cells. Science 1999; 284: 143-147.
44. Muraglia A, Cancedda R and Quarto R. Clonal mesenchymal progenitors from human bone marrow differentiate in vitro according to a hierarchical model. J Cell Sci 2000; 113: 1161-1166.
45. Kortesidis A, Zannettino A, Isenmann S, Shi S, Lapidot T and Gronthos S. Stromalderived factor-1 promotes the growth, survival, and development of human bone marrow stromal stem cells. Blood 2005; 105: 3793-3801.
46. Chang F, Ishii T, Yanai T, Mishima H, Akaogi H, Ogawa T and Ochiai N. Repair of large full-thickness articular cartilage defects by transplantation of autologous uncultured bonemarrow-derived mononuclear cells. J Orthop Res 2008; 26: 18-26.
47. Jackson KA, Majka SM and Wang H. Regeneration of ischemic cardiac muscle and vascular endothelium by adult stem cells. J Clin Invest 2001; 107: 1395-1402.
48. Barry FP, Murphy JM. Mesenchymal Stem Cell: Clinical applications and biological Characterization. Int J Biochem Cellbio 2004; 36: 568-584.
49. Di Nicola M, Carlo-Stella C, Magni M, Milanesi M, Longoni PD, Matteucci P, Grisanti S and Gianni AM. Human bone marrow stromal cells suppress T-lymphocyte proliferation induced by cellular or nonspecific mitogenic stimuli. Blood 2002; 99: 3838-3843.
50. Kuroiwa T, Kakishita E, Hamano T, Kataoka Y, Seto Y, Iwata N, Kaneda Y, Matsumoto K, Nakamura T, Ueki T, Fujimoto J and Iwasaki T. Hepatocyte growthfactor ameliorates acute graft-versus-host disease and promotes hematopoietic function. J Clin Invest 2001; 107: 1365-1373.
51. Tse WT, Pendleton JD, Beyer WM, Egalka MC and Guinan EC. Suppression of allogeneic T-cell proliferation by human marrow stromal cells: implications in transplantation. Transplantation 2003; 75: 389-397.
52. Krampera M, Glennie S, Dyson J, Scott D, Laylor R, Simpson E and Dazzi F. Bone marrow mesenchymal stem cells inhibit the response of naive and memory antigen-specific T cells to their cognate peptide. Blood 2003; 101: 3722-3729.
53. Bartholomew A, Sturgeon C, Siatskas M, Ferrer K, McIntosh K, Patil S, Hardy W, Devine S, Ucker D, Deans R, Moseley A and Hoffman R. Mesenchymal stem cells suppress lymphocyte proliferation in vitro and prolong skin graft survival in vivo. Exp Hematol 2002; 3: 42-48.
54. Zhang W, Ge W, Li C, You S, Liao L, Han Q, Deng W and Zhao RC. Effects of mesenchymal stem cells on differentiation, maturation, and function of human monocyte-derived dendritic cells. Stem Cells Dev 2004; 13: 263-271.
55. Beyth S, Borovsky Z, Mevorach D, Liebergall M, Gazit Z, Aslan H, Galun E and Rachmilewitz J. Human mesenchymal stem cells alter antigen-presenting cell maturation and induce T-cell unresponsiveness. Blood 2005; 105: 2214-2219.
56. Glennie S, Soeiro I, Dyson PJ, Lam EW and Dazzi F. Bone marrow mesenchymal stem cells induce division arrest anergy of activated T cells. Blood 2005; 105: 2821-2827.
57. Puissant B, Barreau C, Bourin P, Clavel C, Corre J, Bousquet C, Taureau C, Cousin B, Abbal M, Laharrague P, Penicaud L, Casteilla L and Blancher A. Immunomodulatory effect of human adipose tissue-derived adult stem cells: comparison with bone marrow mesenchymal stem cells. Br J Haematol 2005; 129: 118-129.
58. Nauta AJ, Kruisselbrink AB, Lurvink E, Willemze R and Fibbe WE. Mesenchymal stem cells inhibit generation and function of both CD34+-derived and monocyte-derived dendritic cells. J Immunol 2006; 177: 2080-2087.
59. Yañez R, Lamana ML, García-Castro J, Colmenero I, Ramírez M and Bueren JA. Adipose tissue-derived mesenchymal stem cells have in vivo immunosuppressive properties applicable for the control of the graft-versus-host disease. Stem Cells 2006; 24: 2582-2591.
60. Cui L, Yin S, Liu W, Li N, Zhang W and Cao Y. Expanded adipose-derived stem cells suppress mixed lymphocyte reaction by secretion of prostaglandin E2. Tissue Eng 2007; 13: 1185-1195.
61. Chiesa S, Morbelli S, Morando S, Massollo M, Marini C, Bertoni A, Frassoni F, Bartolomé ST, Sambuceti G, Traggiai E and Uccelli A. Mesenchymal stem cells impair in vivo T-cell priming by dendritic cells. Proc Natl Acad Sci U S A 2011; 108: 17384-17389.
62. DelaRosa O, Sánchez-Correa B, Morgado S, Ramírez C, Del Río B, Menta R, Lombardo E, Tarazona R and Casado JG. Human adipose-derived stem cells impair natural killer cell function and exhibit low susceptibility to natural killer-mediated lysis. Stem Cells Dev 2012; 21: 1333-1343.
63. Doorn J, Moll G, Le Blanc K, van Blitterswijk C and de Boer J. Therapeutic applications of mesenchymal stromal cells: paracrine effects and potential improvements. Tissue Eng Part B Rev 2012; 18: 101-115.
64. Chabannes D, Hill M, Merieau E, Rossignol J, Brion R, Soulillou JP, Anegon I and Cuturi MC. A role for heme oxygenase-1 in the immunosuppressive effect of adult rat and human mesenchymal stem cells. Blood 2007; 110: 3691-3694.
65. Oh I, Ozaki K, Sato K, Meguro A, Tatara R, Hatanaka K, Nagai T, Muroi K and Ozawa K. Interferon-gamma and NF-kappaB mediate nitric oxide production by mesenchymal stromal cells. Biochem Biophys Res Commun 2007; 355: 956-962.
66. Selmani Z, Naji A, Zidi I, Favier B, Gaiffe E, Obert L, Borg C, Saas P, Tiberghien P, Rouas-Freiss N, Carosella ED and Deschaseaux F. Human leukocyte antigen-G5 secretion by human mesenchymal stem cells is required to suppress T lymphocyte and natural killer function and to induce CD4+CD25highFOXP3+ regulatory T cells. Stem Cells 2008; 26: 212-222.
67. DelaRosa O, Lombardo E, Beraza A, Mancheño-Corvo P, Ramirez C, Menta R, Rico L, Camarillo E, García L, Abad JL, Trigueros C, Delgado M and Büscher D. Requirement of IFN-gamma-mediated indoleamine 2,3-dioxygenase expression in the modulation of lymphocyte proliferation by human adipose-derived stem cells. Tissue Eng Part A 2009; 15: 2795-2806.
68. Ren G, Su J, Zhang L, Zhao X, Ling W, L'Huillie A, Zhang J, Lu Y, Roberts AI, Ji W, Zhang H, Rabson AB and Shi Y. Species variation in the mechanisms of mesenchymal stem cell-mediated immunosuppression. Stem Cells 2009; 27: 1954-1962.
69. Meisel R, Brockers S, Heseler K, Degistirici O, Bülle H, Woite C, Stuhlsatz S, Schwippert W, Jäger M, Sorg R, Henschler R, Seissler J, Dilloo D and Däubener W. Human but not murine multipotent mesenchymal stromal cells exhibit broad-spectrum antimicrobial effector function mediated by indoleamine 2,3-dioxygenase. Leukemia 2011; 25: 648-654.
70. Maccario R, Podestà M, Moretta A, Cometa A, Comoli P, Montagna D, Daudt L, Ibatici A, Piaggio G, Pozzi S, Frassoni F and Locatelli F. Interaction of human mesenchymal stem cells with cells involved in alloantigen-specific immune response favors the differentiation of CD4+ T-cell subsets expressing a regulatory/ suppressive phenotype. Haematologica 2005; 90: 516-255.
71. Gonzalez-Rey E, Gonzalez MA, Varela N, O'Valle F, Hernandez-Cortes P, Rico L, Büscher D and Delgado M. Human adipose-derived mesenchymal stem cells reduce inflammatory and T cell responses and induce regulatory T cells in vitro in rheumatoid arthritis. Ann Rheum Dis 2010; 69: 241-248.
72. Krampera M, Cosmi L, Angeli R, Pasini A, Liotta F, Andreini A, Santarlasci V, Mazzinghi B, Pizzolo G, Vinante F, Romagnani P, Maggi E, Romagnani S and Annunziato F. Role for interferon-gamma in the immunomodulatory activity of human bone marrow mesenchymal stem cells. Stem Cells 2006; 24: 386-398.
73. Prasanna SJ, Gopalakrishnan D, Shankar SR and Vasandan AB. Pro-inflammatory cytokines, IFNgamma and TNFalpha, influence immune properties of human bone marrow and Wharton jelly mesenchymal stem cells differentially. PLoS ONE 2010; 5: e9016.
74. Zonca M, Mancheño-Corvo P, Delarosa O, Mañes S, Büscher D, Lombardo E and Planelles L. APRIL and BAFF proteins increase proliferation of human adipose-derived stem cells through activation of Erk1/2 MAP kinase. Tissue Eng Part A 1012; 18: 852-859.
75. Waterman RS, Tomchuck SL, Henkle SL, Betancourt AM. A new mesenchymal stem cell (MSC) paradigm: polarization into a pro-inflammatory MSC1 or an Immunosuppressive MSC2 phenotype. PLoS ONE 2010; 5: e10088.
76. Krampera M. Mesenchymal stromal cell 'licensing': a multistep process. Leukemia 2011; 25: 1408-1414.
77. Javazon EH, Beggs KJ, Flake AW. Mesenchymal stem cells: Paradoxes of passaging. Exp Hematol 2004; 32: 414-425.
78. Di Nicola M, Carlo-Stella C and Magni M. Human bone marrow stromal cells suppress T-lymphocyte proliferation induced by cellular or nonspecific mitogenic stimuli. Blood 2002; 99: 3838-3843.
79. Bartholomew A, Sturgeon C and Siatskas M. Mesenchymal stem cells suppress lymphocyte proliferation in vitro and prolong skin graft survival in vivo. Exp Hematol 2002; 30: 42-48.
80. Krampera M, Glennie S and Dyson J. Bone marrow mesenchymal stem cells inhibit the response of naive and memory antigen-specific T cells to their cognate peptide. Blood 2003; 101: 3722-3729.
81. Di Nicola M, Carlo-Stella C and Magni M. Human bone marrow stromal cells suppress T-lymphocyte proliferation induced by cellular or nonspecific mitogenic stimuli. Blood 2002; 99: 3838-3843.
82. Aggarwal S and Pittenger MF. Human mesenchymal stem cells modulate allogeneic immune cell responses. Blood 2005; 105: 1815-1822.
83. Jiang XX, Zhang Y and Liu B. Human mesenchymal stem cells inhibit differentiation and function of monocyte-derived dendritic cells. Blood 2005; 105: 4120-4126.
84. Beyth S, Borovsky Z and Mevorach D. Human mesenchymal stem cells alter antigen-presenting cell maturation and induce T-cell unresponsiveness. Blood 2005; 105: 2214-2219.
85. Corcione A, Benvenuto F and Ferretti E. Human mesenchymal stem cells modulate B-cell functions. Blood 2006; 107: 367-372.
86. Bartholomew A, Sturgeon C and Siatskas M. Mesenchymal stem cells suppress lymphocyte proliferation in vitro and prolong skin graft survival in vivo. Exp Hematol 2002; 30: 42-48.
87. Lazarus HM, Koc ON and Devine SM. Cotrans-plantation of HLA identical sibling culture-expanded mesenchymal stem cells and hematopoietic stem cells in hematologic malignancy patients. Biol Blood Marrow Transplant 2005; 11: 389-398.
88. Le Blanc K, Rasmusson I and Sundberg B. Treatment of severe acute graft-versus-host disease with third party haploidentical mesenchymal stem cells. Lancet 2004; 363: 1439-1441
89. Zappia E, Casazza S and Pedemonte E. Mesenchymal stem cells ameliorate experimental autoimmune encephalomyelitis inducing T-cell energy. Blood 2005; 106: 1755-1761.
90. Djouad F, Fritz V and Apparailly F. Reversal of the immunosuppressive properties of mesenchymal stem cells by tumor necrosis factor alpha in collagen-induced arthritis. Arthritis Rheum 2005; 52: 1595-1603.
91. Liechty KW, MacKenzie TC, Shaaban AF, Radu A, Moseley AM, Deans R, Marshak DR and Flake AW. Human mesenchymal stem cells engraft and demonstrate site-specific differentiation after in utero transplantation in sheep. Nature Medicine 2000; 6: 1282-1286.
92. Shake JG, Gruber PJ, Baumgartner WA, Senechal G, Meyers J, Redmond JM, Pittenger MF and Martin BJ. Mesenchymal stem cell implantation in a swine myocardial infarct model: engraftment and functional effects. Ann Thorac Surg 2002; 73: 1919-1925.
93. Wang L, Li Y, Chen X, Chen J, Gautam SC, Xu Y and Chopp M. MCP-1, MIP-1, IL-8 and ischemic cerebral tissue enhance human bone marrow stromal cell migration in interface culture. Hematology 2002; 7: 113-117.
94. Murphy M, Fink DJ, Hunziker EB and Barry FP. Stem cell therapy in a caprine model of osteoarthritis. Arthritis Rheum 2003; 48: 3464-3474.
95. Rombouts WJ and Ploemacher RE. Primary murine MSC show highly efficient homing to the bone marrow but lose homing ability following culture. Leukemia 2003; 17: 160-170.
96. Ringe J, Strassburg S and Neumann K. To-wards in situ tissue repair: Human mesenchymal stem cells express chemokine receptors CXCR1, CXCR2 and CCR2, and migrate upon stimulation with CXCL8 but not CCL2. J Cell Biochem 2007; 101: 135-146.
97. Ponte AL, Marais E and Gallay N. The in vitro migration capacity of human bone marrow mesenchymal stem cells: Comparison of chemokine and growth factor chemotactic activities. Stem Cells 2007; 25: 1737-1745.
98. Ruster B, Gottig S and Ludwig RJ. Mesenchymal stem cells (MSCs) display coordinated rolling and adhesion behavior on endothelial cells. Blood 2006; 108: 3938-3944.
99. Pittenger MF, Mackay AM and Beck SC. Multi-lineage potential of adult human mesenchymal stem cells. Science 1999; 284: 143-147.
100. Ruster B, Gottig S and Ludwig RJ. Mesenchymal stem cells (MSCs) display coordinated rolling and adhesion behavior on endothelial cells. Blood 2006; 108: 3938-3944.
101. Shur I, Marom R and Lokiec F. Identification of cultured progenitor Cell from human marrow stroma. J Cell Biochem 2002; 87: 51-57.
102. Bruder SP, Ricalton NS and Boynton RE. Mesenchymal stem cell surface antigen SB-10 corresponds to activated leukocyte cell adhesion molecule and is involved in osteogenic differentiation. J Bone Miner Res 1998; 13: 655-663.
103. Minguell JJ, Erices A and Conget P. Mesenchymal stem cells. Exp Biol Med 2001; 226: 507-520.
104. Krampera M, Pizzolo G and Aprili G. Mesenchymal stem cells for bone, cartilage, tendon and skeletal muscle repair. Bone 2006; 39: 678-683.
105. Murphy JM, Dixon K, Beck S, Fabian D, Feldman A and Barry F. Reduced chondrogenic and adipogenic activity of mesenchymal stem cells from patients with advanced osteoarthritis. Arthritis Rheum 2002; 46: 704-713.
106. Fernandes JC, Martel-Pelletier J and Pelletier JP. The role of cytokines in osteoarthritis pathophysiology. Biorheology 2002; 39: 237-246.
107. Goldring MB. Anticytokine therapy for osteoarthritis. Expert Opin Biol Ther 2001; 1: 817-829.
108. Tabbara IA, Zimmerman K, Morgan C and Nahleh Z. Allogeneic hematopoietic stem cell transplantation: complications and results. Arch Intern Med 2002; 162: 1558-1566.
109. Orlic D, Kajstura J, Chimenti S, Jakoniuk I, Anderson SM, Li B, Pickel J, McKay R, Nadal-Ginard B, Bodine DM, Leri A and Anversa P. Bone marrow cells regenerate infarcted myocardium. Nature 2001; 410: 701-705.
110. Stamm C, Westphal B, Kleine HD, Petzsch M, Kittner C, Klinge H, Schumichen C, Nienaber CA, Freund M and Steinhoff G. Autologous bone-marrow stem-cell transplantation for myocardial regeneration. Lancet 2003; 361: 45-46.
111. Deb A, Wang S, Skelding KA, Miller D, Simper D and Caplice NM. Bone marrow-derived cardiomyocytes are present in adult human heart: a study of gender-mismatched bone marrow transplantation patients. Circulation 2003; 107: 1247-1249.
112. Saito T, Kuang JQ, Bittira B, Al-Khaldi A and Chiu RC. Xenotransplant cardiac chimera: immune tolerance of adult stem cells. Ann Thorac Surg 2002; 74: 19-24.
113. Gussoni E, Soneoka Y, Strickland CD, Buzney EA, Khan MK, Flint AF, Kunkel LM and Mulligan RC. Dystrophin expression in the mdx mouse restored by stem cell transplantation. Nature1999; 401: 390-394.
114. Toma C, Pittenger MF, Cahill KS, Byrne BJ and Kessler PD. Human mesenchymal stem cells differentiate to a cardiomyocyte phenotype in the adult murine heart. Circulation 2002; 105: 93-98.
115. Ortiz LA, Gambelli F, McBride C, Gaupp D, Baddoo M, Kaminski N and Phinney DG. Mesenchymal stem cell engraftment in lung is enhanced in response to bleomycin exposure and ameliorates its fibrotic effects. Proc Natl Acad Sci U S A 2003; 100: 8407-8411.
116. Shihabuddin LS, Horner PJ, Ray J and Gage FH. Adult spinal cord stem cells generate neurons after transplantation in the adult dentate gyrus. J Neurosci 2000; 2: 8727-8735.
117. Teng YD, Lavik EB, Qu X, Park KI, Ourednik J, Zurakowski D, Langer R and Snyder EY. Functional recovery following traumatic spinal cord injury mediated by a unique polymer scaffold seeded with neural stem cells. Proc Natl Acad Sci U S A 2002; 99: 3024-3029.
118. Kim JH, Auerbach JM, Rodriguez-Gomez JA, Velasco I, Gavin D, Lumelsky N, Lee SH, Nguyen J, Sanchez-Pernaute R, Bankiewicz K and McKay R. Dopamine neurons derived from embryonic stem cells function in an animal model of Parkinson's disease. Nature 2002; 418: 50-56.
119. Sanchez-Ramos JR. Neural cells derived from adult bone marrow and umbilical cord blood. J Neurosci Res 2002; 69: 880-893.
120. Mezey E, Key S, Vogelsang G, Szalayova I, Lange GD and Crain B. Transplanted bone marrow generates new neurons in human brains. Proc Natl Acad Sci U S A 2003; 100: 1364-1369.
121. Muschler GF, Nitto H, Matsukura Y, Boehm C, Valdevit A, Kambic H, Davros W, Powell K and Easley K. Spine fusion using cell matrix composites enriched in bone marrow-derived cells. Clinical Orthop Relat Res 2003; 102-118.
122. Quarto R, Mastrogiacomo M, Cancedda R, Kutepov SM, Mukhachev V, Lavroukov A, Kon E and Marcacci M. Repair of large bone defects with the use of autologous bone marrow stromal cells. N Engl J Med 2001; 344: 385-386.
123. Krebsbach PH, Mankani MH, Satomura K, Kuznetsov SA and Robey PG. Repair of craniotomy defects using bone marrow stromal cells. Transplantation 1998; 66: 1272-1278.
124. Ponticiello MS, Schinagl RM, Kadiyala S and Barry FP. Gelatin-based resorbable sponge as a carrier matrix for human mesenchymal stem cells in cartilage regeneration therapy. J Biomed Mater Res 2000; 52: 246-255.
125. Solchaga LA, Gao J, Dennis JE, Awadallah A, Lundberg M, Caplan AI and Goldberg VM. Treatment of osteochondral defects with autologous bone marrow in a hyaluronan-based delivery vehicle. Tissue Engineering 2002; 8: 333-347.
126. Young RG, Butler DL, Weber W, Caplan AI, Gordon SL and Fink DJ. Use of mesenchymal stem cells in a collagen matrix for Achilles tendon repair. J Orthop Res 1988; 16: 406-413.
127. Horwitz EM, Prockop DJ, Fitzpatrick LA, Koo WW, Gordon PL, Neel M, Sussman M, Orchard P, Marx JC, Pyeritz RE and Brenner MK. Transplantability and therapeutic effects of bone marrow-derived mesenchymal cells in children with osteogenesis imperfecta. Nat Med 1999; 5: 309-313.
128. Koc ON, Day J, Nieder M, Gerson SL, Lazarus HM and Krivit W. Allogeneic mesenchymal stem cell infusion for treatment of metachromatic leukodystrophy (MLD) and Hurler syndrome (MPS-IH). Bone Marrow Transplant 2002; 30: 215-222.
129. Fouillard L, Bensidhoum M, Bories D, Bonte H, Lopez M, Moseley AM, Smith A, Lesage S, Beaujean F, Thierry D, Gourmelon P, Najman A and Gorin NC. Engraftment of allogeneic mesenchymal stem cells in the bone marrow of a patient with severe idiopathic aplastic anemia improves stroma. Leukemia 2003; 17: 474-476.
130. Arinzeh TL, Peter SJ, Archambault MP, Van Den Bos C, Gordon S, Kraus K, Smith A and Kadiyala S. Allogeneic mesenchymal stem cells regenerate bone in a critical-sized canine segmental defect. J Bone Joint Surg Am 2003; 85A: 1927-1935.
131. Bruder SP, Kurth AA, Shea M, Hayes WC, Jaiswal N and Kadiyala S. Bone regeneration by implantation of purified, culture-expanded human mesenchymal stem cells. J Orthop Res 1998; 16: 155-162.
132. Ferrari G and Mavilio F. Myogenic stem cells from the bone marrow: a therapeutic alternative for muscular dystrophy? Neuromuscul Disord 2002; 12: S7-S10.
133. Zarnett R and Salter RB. Periosteal neochondrogenesis for biologically resurfacing joints: its cellular origin. Can J Surg 1989; 32: 171-174.
134. O'Driscoll SW, Saris DB, Ito Y and Fitzimmons JS. The chondrogenic potential of periosteum decreases with age. J Orthop Res 2001; 19: 95-103.
135. Noth U, Osyczka AM, Tuli R, Hickok NJ, Danielson KG and Tuan RS. Multilineage mesenchymal differentiation potential of human trabecular bone-derived cells. J Orthop Res 2002; 20: 1060-1069.
136. Sottile V, Halleux C, Bassilana F, Keller H and Seuwen K. Stem cell characteristics of human trabecular bone-derived cells. Bone 2002; 30: 699-704.
137. Tuli R, Seghatoleslami MR, Tuli S, Wang ML, Hozack WJ, Manner PA, Danielson KG and Tuan RS. A simple, high-yield method for obtaining multipotential mesenchymal progenitor cells from trabecular bone. Mol Biotechnol 2003; 23: 37-49.
138. De Ugarte DA, Morizono K, Elbarbary A, Alfonso Z, Zuk PA, Zhu M, Dragoo JL, Ashjian P, Thomas B, Benhaim P, Chen I, Fraser J and Hedrick MH. Comparison of multi-lineage cells from human adipose tissue and bone marrow. Cells Tissues Organs 2003; 174: 101-109.
139. Dragoo JL, Samimi B, Zhu M, Hame SL, Thomas BJ, Lieberman JR, Hedrick MH and Benhaim P. Tissue-engineered cartilage and bone using stem cells from human infrapatellar fat pads. J Bone Joint Surg Br 2003; 85: 740-747.
140. Gronthos S, Franklin DM, Leddy HA, Robey PG, Storms RW and Gimble JM. Surface protein characterization of human adipose tissue-derived stromal cells. J Cell Physiol 2001; 189: 54-63.
141. Wickham M, Erickson GR, Gimble JM, Vail TP and Guilak F. Multipotent stromal cells derived from the infrapatellar fat pad of the knee. Clin Orthop Relat Res 2003; 196-212.
142. De Bari C, Dell'Accio F, Tylzanowski P and Luyten FP. Multipotent mesenchymal stem cells from adult human synovial membrane. Arthritis Rheum 2001; 44: 1928-1942.
143. Jankowski RJ, Deasy BM and Huard J. Muscle-derived stem cells. Gene Therapy 2002; 9: 642-647.
144. Noort WA, Kruisselbrink AB, in't Anker PS, Kruger M, van Bezooijen RL, de Paus RA, Heemskerk MH, Löwik CW, Falkenburg JH, Willemze R, Fibbe WE. Mesenchymal stem cells promote engraftment of human umbilical cord blood-derived CD34(+) cells in NOD/SCID mice. Exp Hematol 2002; 30: 870-878.
145. Miura M, Gronthos S, Zhao M, Lu B, Fisher LW, Robey PG and Shi S. SHED: stem cells from human exfoliated deciduous teeth. Proc Natl Acad Sci U S A 2003; 100: 5807-5812.
146. De Bari C, Dell Accio F, Vandenabeele F, Vermeesch JR, Raymackers JM and Luyten FP. Skeletal muscle repair by adult human mesenchymal stem cells from synovial membrane. J Cell Biol 2003; 160: 909-918.
147. Gimble JM. Adipose tissue-derived therapeutics. Expert Opin Biol Ther 2003; 3: 705-713.
148. Sensebé L. Clinical grade production of Mesenchymal Stem cells. Biomed Mater Eng 2008; 18: S3-S10.
149. Ancans J. Cell Therapy Medicinal product regulatory framework in Europe and its application for MSC based therapy development. Front Immunol 2012; 3: 253.